Health officials have given a life-extending drug the green light for widespread NHS, giving hope to thousands of men facing a "death sentence" from prostate cancer.
The National Institute for Health and Care Excellence (Nice) said the drug enzalutamide, also known as xtandi, should be considered for use in the treatment of men with hormone relapsed prostate cancer that has spread to other parts of the body.
Nice said in its draft guidance that it was pleased to recommend the drug, which is manufactured by Astellas Pharma, for patients who have few other treatment options left.
More top news
Labour is facing a disastrous election night in Scotland, with the party in danger of finishing third behind the SNP and the Conservatives.
A Labour councillor who thought he had lost his seat was re-elected after a bundle of votes was found "under a Tory pile".
A sailor has been rescued after two months lost at sea, during which he was forced to eat seagulls for survival.